drugset / Trial / NCT02509481
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Phase 2/3
Completed
2712 enrolled
Colorado State University
Centre Muraz · collabInstitut de Recherche en Sciences de la Sante, Burkina Faso · collabMinistère de la Santé du Burkina Faso · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether repeated ivermectin mass drug administrations to Burkinabé villagers, performed in three week intervals over the rainy-season, is well-tolerated and safe, and also effective in reducing local malaria transmission and thus clinical malaria episodes in treated village children.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-11
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | 150 ug/kg | Oral |
| Background | Albendazole | Small molecule | 400 mg | Oral |